Search for dissertations about: "tuberculosis treatment"
Showing result 1 - 5 of 102 swedish dissertations containing the words tuberculosis treatment.
-
1. Interplay of human macrophages and Mycobacterium tuberculosis phenotypes
Abstract : Mycobacterium tuberculosis (Mtb) is the pathogen causing tuberculosis (TB), a disease most often affecting the lung. 1.5 million people die annually due to TB, mainly in low-income countries. READ MORE
-
2. Epidemiological aspects of tuberculosis in Guinea-Bissau, West Africa
Abstract : Tuberculosis (TB) has plagued the humanity for several thousands of years. The bacteria causing TB is mainly spread from person to person as an aerosol transmission. It is estimated that one third of the world’s population is infected with the disease; about 10% of these will develop active TB during their lifetime. READ MORE
-
3. Towards individualised treatment of tuberculosis
Abstract : Each year, around 10 million of individuals develop active tuberculosis (TB). Worldwide, TB is the leading cause of death from an infectious agent surpassing both malaria and HIV. READ MORE
-
4. Pharmacometric models to inform dose selection and study design : Applied in hemophilia and tuberculosis
Abstract : While tuberculosis is a global pandemic, hemophilia is a rare disease which many have not heard of. Due to tuberculosis mainly being a problem in developing countries and hemophilia being a rare disease, they are not as heard of as other diseases such as cancer or metabolic diseases which are on the rise in Western societies. READ MORE
-
5. Novel Pharmacometric Methods for Informed Tuberculosis Drug Development
Abstract : With approximately nine million new cases and the attributable cause of death of an estimated two millions people every year there is an urgent need for new and effective drugs and treatment regimens targeting tuberculosis. The tuberculosis drug development pathway is however not ideal, containing non-predictive model systems and unanswered questions that may increase the risk of failure during late-phase drug development. READ MORE